Showing 1,721 - 1,740 results of 101,238 for search '(( 50 ng decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 1721
  2. 1722
  3. 1723

    The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

    Published 2025
    “…<p dir="ltr">HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intramuscular (DMPA-IM). We investigated the effects of these progestin-only injectable contraceptives on serum testosterone and sex hormone binding globulin (SHBG) levels, since these may play a role in sexual behavior and HIV acquisition. …”
  4. 1724
  5. 1725

    Structure, Insertion Electrochemistry, and Magnetic Properties of a New Type of Substitutional Solid Solutions of Copper, Nickel, and Iron Hexacyanoferrates/Hexacyanocobaltates by Antje Widmann (2966013)

    Published 2002
    “…The dependencies of lattice parameters on composition exhibit in all series of solid solutions studied similar, although small, deviations from ideality, which correlate with the electrochemical behavior. Finally, a series of solid solutions of the composition KNi<sub>0.5</sub><sup>II</sup>Cu<sub>0.5</sub><sup>II</sup>[Fe<sup>III</sup>(CN)<sub>6</sub>]<sub>1</sub><sub>-</sub><i><sub>x</sub></i>[Co<sup>III</sup>(CN)<sub>6</sub>]<i><sub>x</sub></i>, where both the nitrogen- and carbon-coordinated metal ions are mixed populated and were synthesized and characterized. …”
  6. 1726
  7. 1727

    Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage by Lucia Reh (546554)

    Published 2018
    “…To enable this, properties that render HIV-1 envelopes (Env) capable of eliciting bnAb responses need to be defined. Here, we followed the evolution of the V2 apex directed bnAb lineage VRC26 in the HIV-1 subtype C superinfected donor CAP256 to investigate the phenotypic changes of the virus populations circulating before and during the early phases of bnAb induction. …”
  8. 1728
  9. 1729
  10. 1730
  11. 1731
  12. 1732
  13. 1733
  14. 1734
  15. 1735
  16. 1736
  17. 1737
  18. 1738
  19. 1739
  20. 1740